Skip to main navigation Skip to search Skip to main content

Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone

  • Owen Cronin
  • , Laura Forsyth
  • , Kirsteen Goodman
  • , Steff C. Lewis
  • , Catriona Keerie
  • , Allan Walker
  • , Mary Porteous
  • , Roseanne Cetnarskyj
  • , Lakshminarayan R. Ranganath
  • , Peter L. Selby
  • , Geeta Hampson
  • , Rama Chandra
  • , Shu Ho
  • , Jon H. Tobias
  • , Steven Young-Min
  • , Malachi J. McKenna
  • , Rachel K. Crowley
  • , William D. Fraser
  • , Luigi Gennari
  • , Ranuccio Nuti
    • Maria Luisa Brandi, Javier Del Pino-Montes, Jean-Pierre Devogelaer, Anne Durnez, Giancarlo Isaia, Marco Di Stefano, Núria Guañabens, Josep Blanch, Markus J. Seibel, John P. Walsh, Mark A. Kotowicz, Geoffrey C. Nicholson, Emma L. Duncan, Gabor Major, Anne Horne, Nigel L. Gilchrist, Maarten Boers, Gordon D. Murray, Keith Charnock, Diana Wilkinson, R. Graham G Russell, Stuart H. Ralston (Lead / Corresponding author)

    Research output: Contribution to journal › Article › peer-review

    17   Link opens in a new tab Citations (Scopus)
    198 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Zoledronate in the prevention of Paget's (ZiPP): protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget's disease of bone'. Together they form a unique fingerprint.
    Sort by

    Medicine and Dentistry

    Keyphrases